Ace Therapeutics, a premier preclinical CRO, announces its dedicated preclinical ophthalmic drug development services to help expedite the discovery and development of cutting-edge treatments for ocular diseases. At the core of innovation and compliance is Ace Therapeutics, which assists pharma and biotech firms to launch successful ophthalmic therapies. The development of drugs for the...

Protheragen, a reputable research service provider in the life science industry, proudly introduces its comprehensive therapeutic development solutions covering a full spectrum of ophthalmic drug preclinical R&D services tailored specifically for ophthalmic research. These innovative initiatives help researchers streamline the complex process of developing effective therapies for eye...